Log in


  • 31 Mar 2021 1:09 PM | Michele O'Bright (Administrator)

    We are pleased to announce that we received close to 600 abstract submissions for the ISDE 2021 Virtual Congress! The program committee is looking forward to reviewing all proposals and we will send out result notifications in May.

    Watch this space for the preliminary scientific program – it will be announced on the congress website very soon.

    Next month will also see the opening of the congress registrations.

  • 29 Mar 2021 7:30 PM | Michele O'Bright (Administrator)

    Among the most exotic locations for an ISDE World Congress was Kyoto, the site of the 5th World Congress (Figure 1). This meeting was hosted by Congress President Prof. Kin-ichi Nabeya (Figure 2), and the ISDE President was Prof. David Skinner in August 1992. Attendance was 650 strong, representing 45 countries. Submitting abstracts numbered over 500, representing 32 countries. The attendees and accompanying persons enjoyed the beauty and culture of Kyoto immensely (Figure 3). Side trips included a visit to an old capitol of Japan, Nara, and many attendees tried out a traditional ryokan (bed and breakfast) to experience what life was like a century or more before. ISDE milestones marked during this Congress included incorporation of the journal Gullet, edited by Prof. Glyn Jamieson, into Diseases of the Esophagus, and Prof J. Rudiger Siewert succeeded Prof Sergio Stipa as journal editor. The Congress proceedings were published by Springer as Recent Advances in Diseases of the Esophagus, edited by Profs. Nabeya and Hanaoka and Dr. Nogami (Figure 4), which included over 1,000 chapters covering all aspects of esophageal disease.

    The 6th ISDE was held in the international design capital of Milan, Italy, in August 1995. The ISDE President was Prof. Skinner, and the hosts were Congress President Prof. Alberto Peracchia (Figure 5) and his colleague, Prof. Ermanno Ancona. The program was outstanding, including 51 invited lectures, 365 oral abstracts, 108 posters, 68 videos, and a memorable lecture by Mr. Ronald Belsey on the history of clinical esophagology. Over 750 attendees represented nearly 40 different countries. Interest was expressed in encouraging broader membership outside of surgery, and appropriate changes were made to the constitution and bylaws to permit this. The social program was highlighted by regional dress (Figure 6) and, of course, by operatic music (Figure 7). The proceedings were published as Recent Advances in Diseases of the Esophagus, containing more than 1,100 pages divided into 20 sections and including more than 700 authors. It was edited by Peracchia, Rosati, Bonavina, Fumagalli, Bona, and Chella.

    Figure 1. The announcement for the 5th ISDE World Congress.

    Figure 2. Prof. Nabeya, his wife, and Prof. Toni Lerut at the 5th ISDE World Congress.

    Figure 3. Social events included learning traditional flower arranging.

    Figure 4. Recent Advances in Diseases of the Esophagus was published based on proceedings of the 5th ISDE Congress.

    Figure 5. Prof. Peracchia, President of the 6th ISDE World Congress.

    Figure 6. Prof. Peracchia greeting by city officials during the opening ceremonies.

    Figure 7. An enthusiastic rendering of a favorite Italian operatic piece.

  • 26 Mar 2021 7:39 PM | Anonymous

    Esophageal cancer is among the 6th to 8th cause of cancer mortality according to the Global Cancer Observatory. The esophagus is a muscular tube that connects the throat to the stomach. Its symptoms cause a significant impact on patients lives and are often: swallow disorder (dysphagia), unintentional weight loss, heartburn and chest pain. The early treatment for esophageal cancer is imperative for a better prognosis and enhances the chance of the patient survivor. Esophagectomy has an important role in the cancer treatment and minimally invasive approach has been achieving an increasingly solid result in recent years.

    The ISDE hosted a virtual tumour board on the multidisciplinary management of esophageal neoplasm that touched on cancer surgery, oncological treatment, management of surgery complications and endoscopic treatment. This live event was held on March 23, 2021 and moderated by Simon Law, University of Hong Kong (Hong Kong) and Richard van Hillegersberg, University Medical Center Utrecht (The Netherlands).

    Case 1 | Post chemoradiation esophageal stenosis

    Case 2 | Shifting boundaries in T1b esophageal cancer

    Case 3 | Oligometastatic disease

    Case 3 recording can only be viewed on Youtube. Click the image to view.

    Case 4 | Unresectable Case

    ISDE wishes to recognize and thank the following individuals for their contributions to this virtual tumour board:

    • Trevor Leong, Radiation Oncologist, Peter MacCallum Cancer Centre (Australia)
    • Daniela Molena, Surgeon, Memorial Sloan Kettering Cancer Center (USA)
    • Ken Kato, Medical Oncologist, National Cancer Center Hospital (Japan)
    • Christiane Bruns, Surgeon, University Hospital Cologne (Germany)
    • Jacques Bergman, Gastroenterologist (The Netherlands)

    If you are interested in this you may also be interested in the Esophageal Cancer Playlist too.

    Join our community

    Become a member 

    Subscribe to ISDE Diseases of the Esophagus on Youtube

    Facebook @ISDEsophagus 

    Twitter @ISDE_net

    Instagram @esophagram

  • 26 Feb 2021 4:21 PM | Michele O'Bright (Administrator)

    The ISDE is happy to endorse programs of sufficient relevance and quality developed by other societies or organizations that align with its mission. Endorsed meetings will appear on the Industry Events section of the ISDE website, in the newsletter and on social media. For more information and to receive a copy of the ISDE Policy on Meeting Endorsement please contact info@isde.net.

  • 26 Feb 2021 4:19 PM | Michele O'Bright (Administrator)

    DOTE Volume 34, Issue 2 | Editor's Choice
    Free Article

    Achalasia Quality of Life (ASQ) and Eckardt scores are two patient-reported instruments widely used to assess symptom severity in achalasia patients. ASQ is validated and reliable. Although Eckardt is commonly used, it has not been rigorously assessed for validity or reliability. This study aims to evaluate (i) the accuracy of Eckardt and ASQ for assessing improvement post-treatment (predictive validity), (ii) accuracy of Eckardt and ASQ for assessing improvement post-treatment with pneumatic dilatation (PD) versus surgical myotomy (predictive validity), and (iii) convergent validity of Eckardt and ASQ tools. Read the full accuracy of achalasia quality of life article for free.

  • 26 Feb 2021 4:17 PM | Michele O'Bright (Administrator)

    DOTE Volume 34, Issue 2 | Editor's Choice
    Free Article

    Esophagectomy is the gold-standard treatment for esophageal cancer; however, postoperative anastomotic leakage remains the primary concern for surgeons. No consensus exists on the optimal investigations to predict an anastomotic leak. This systematic review aims to identify a single test or combination of tests with acceptable sensitivity and specificity to identify anastomotic leak after esophagectomy and to formulate a diagnostic algorithm to facilitate surgical decision-making. Read the full diagnosing anastomotic article for free.

  • 26 Feb 2021 4:14 PM | Michele O'Bright (Administrator)

    Checkout the latest DOTE issue for articles on Benign Esophageal and Malignant Esophageal Diseases; See the full table of contents.

  • 24 Feb 2021 8:11 PM | Michele O'Bright (Administrator)

    Abstract submission is now open for the 17th ISDE World Congress for Esophageal Diseases! With ePoster and Oral presentation opportunities available for different areas of esophageal research, we encourage you to present your findings to the esophageal community and make a difference!

    View our abstract submission guidelines: The deadline is March 15, 2021.

  • 24 Feb 2021 8:01 PM | Michele O'Bright (Administrator)

    Written by Christophe Faure on behalf of the INoEA Pediatric Gastroenterology, Sainte-Justine UHC Professor of Pediatrics, Université de Montréal, Montréal, QC, Canada

    Pediatric and adult patients born with esophageal atresia with or without tracheoesophageal fistula (EA/TEF) are at risk for respiratory infections and severe complications. This is mostly related to the association of the esophageal condition with tracheomalacia, asthma or gastroesophageal reflux. Taking advantage of the International Network of Esophageal Atresia (INoEA) we aimed to investigate the impact of the SARS-CoV-2 in patients previously operated of esophageal atresia.

    An international survey was conducted amongst the INoEA members starting on April 2020 and still recruiting (for information www.inoea.org). Information on demography, type of esophageal atresia, co-morbidities, clinical data regarding EA-TEF, symptoms suggestive of the SARS-CoV-2 infection, complications, hospitalization, and therapies administered for COVID-19 was collected for all patients who were reported. The study was approved by the Sainte-Justine University Health Centre IRB.

    Seventeen patients (14 children, 9 males) with a mean age of 69.4 months (range 12 months – 30 years) were reported from Italy, Argentina, Switzerland, Netherland, Canada, France, India and Turkey. All patients had a documented infection confirmed by PCR or rapid test except 3 children who were considered positive after a contact with an infected person.

    Nine patients (53%) had a type C EA-TEF, 4 (23%) a type A, 3 an other type. Eleven (65%) had chronic respiratory problems (asthma n=3, tracheomalacia n=5, recurrent respiratory tract infections n=3). Six (35%) had associated cardiac malformations. Seven (41%) had an history of recurrent anastomotic strictures. PPI (n=4, 23%), swallowed budesonide (n=3, 18%), inhaled bronchodilatators or corticosteroids (n=5, 29%) were the most frequent reported medications. Symptoms at presentation included cough (n=5, 29%), fever (n=2, 12%), vomiting (n=2, 12%), rhinitis (n=1, 6%) and abnormal taste or anosmia (n=2, 12%).

    Six patients (35%, 4 children and 2 adults) were hospitalized. None needed any respiratory support except one who was temporarily put on nasal oxygen. No specific treatment directed to SARS-CoV-2 was administered. No patient was admitted in ICU. All six patients were discharged with an uneventful outcome. The remaining 11 patients had similarly an uneventful outcome.

    In conclusion, in patients with EA/TEF, the SARS-CoV-2 infection does not represent a risk for severe respiratory complications or severe outcome. The high rate of hospitalization is probably due to a selection bias of the present survey and may be linked to a highest awareness of the health providers towards the population of EA/TEF patients.

  • 24 Feb 2021 7:07 PM | Michele O'Bright (Administrator)

    Written by Prof. Mark Ferguson, University of Chicago, USA

    The 1st and 2nd ISDE World Congresses were an outgrowth of parallel efforts in Japan and in the West to develop international collaboration among physicians and surgeons treating esophageal diseases. During the 2nd Congress in Rome, Professor Rudiger Siewert proposed that a joint congress be held by the two groups in 1986 as a first step in creating a merger between them.

    Thus, the 3rd ISDE World Congress was hosted in 1986 by Professor Siewert (Congress President) in Munich at the Technical University, with able support from Professor Arnulf Holscher (Figure 1). Professor Kyoshi Inokuchi was named ISDE President, and Professor Nakayama was named Honorary ISDE President (Figure 2). The Congress overlapped with the famous Oktoberfest event in Munich, and the juxtaposition was celebrated in part by having large steins of beer served starting as early as the 10:00 AM break between sessions. The scientific discourse was lively, and few will forget the social events, which were livelier still (Figure 3)! Over 600 abstracts were submitted for the meeting, and registration expanded considerably. The Congress was joined by other esophageal organizations centered in Europe, including Group European Etude Maladies Oesophage (GEEMO) and the International Organization for Statistical Studies of Esophageal Disease (OESO), the latter founded by Professors Lortat-Jacob and Robert Giuli. Professor Lortat-Jacob was named the first Honorary Member of the ISDE. The Congress proceedings were published as Diseases of the Esophagus: Pathophysiology, Diagnosis, Conservative and Surgical Treatment, published by Springer-Verlag and edited by Professors Siewert and Holsher.

    Using the model established by the 1986 Congress, the 4th ISDE Congress was held in Chicago in 1989, hosted by Professors David Skinner, Alex Little, and Mark Ferguson. The Congress venue was the newly opened Fairmont Hotel (Figure 5). The Congress President was Professor Skinner (Figure 4), and Professor Inokuchi was ISDE President. Three Honorary Memberships were awarded to Professors Ronald Belsey (Bristol, England), Guam Bee Ong (Hong Kong), and Spencer Payne (Rochester, MN). Nearly 600 abstracts and films were submitted on benign and malignant disease, and 336 were selected for presentation across four different venues. The social program was highlighted by a performance by the Queen of the Blues, Koko Taylor (Figure 6). The proceedings of the Congress were published in two volumes by Futura as Diseases of the Esophagus, Volume I: Malignant Diseases, and Diseases of the Esophagus, Volume II: Benign Diseases (Figure 7), edited by Professors Skinner, Little, and Ferguson.

    Figure 1. Registration activities at the 3rd ISDE Congress held in Munich.

    Figure 2. Professors Siewert and Nakayama confer at an ISDE committee meeting during the 3rd ISDE Congress.

    Figure 3. The social events during the 3rd ISDE Congress often included folk dancing and traditional local musical entertainment.

    Figure 4. David B. Skinner, MD, 4th ISDE Congress President.

    Figure 5. Fairmont Hotel, Chicago, site of the 4th ISDE Congress.

    Figure 6. Koko Taylor, Queen of the Blues.

    Figure 7. Diseases of the Esophagus volumes.

Affiliated Societies

International  Interdisciplinary  Everything Esophageal

The International Society for Diseases of the Esophagus is a 501(c)3 non-profit organization.

General Inquiries: info@isde.net
Membership Questions: membership@isde.net

Powered by Wild Apricot Membership Software